Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Autor: Chang, Yong S., Graves, Bradford, Guerlavais, Vincent, Tovar, Christian, Packman, Kathryn, To, Kwong-Him, Olson, Karen A., Kesavan, Kamala, Gangurde, Pranoti, Mukherjee, Aditi, Baker, Theresa, Darlak, Krzysztof, Elkin, Carl, Filipovic, Zoran, Qureshi, Farooq Z., Cai, Hongliang, Berry, Pamela, Feyfant, Eric, Shi, Xiangguo E., Horstick, James, Annis, D. Allen, Manning, Anthony M., Fotouhi, Nader, Nash, Huw, Vassilev, Lyubomir T., Sawyer, Tomi K.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2013 Sep 01. 110(36), 14519-14519.

Externí odkaz: https://www.jstor.org/stable/42713145